Neurodegenerative Diseases Market to 2018

Bharat Book Bureau

“Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff”. A highly dynamic market scenario is expected in Neurodegenerative diseases in the next few years, with a number of patent expiries and anticipated new drug approvals. The market for Alzheimer’s disease has not seen any recent major breakthroughs, and is expected to experience a decline due to the patent expiry of several major products. The market for Parkinson’s disease, on the other hand, is expected to experience growth due to the anticipated approval of expensive products such as Duodopa in the US, in spite of the fact that it will soon hit its own patent cliff. Additionally, the overall aging of populations the developed world is expected to increase the number of patients suffering from these diseases due to their relatively high prevalence in the elderly.

- The report analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal trends in Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease (HD). - The current therapeutic environment in the treatment of AD, PD, HD and ALS across the top seven developed markets, including the US, Germany, France, the UK, Italy, Spain and Japan. - Market data on the geographical landscape and therapeutic landscape, including market size, annual cost of therapy, treatment usage patterns such as disease population and prescription populations.

- Market forecasts for all four indications across the US, the top five countries in Europe (EU5) - Germany, France, the UK, Italy, and Spainas well as Japan. - Key market drivers and barriers

- The major deals that have taken place in the Neurodegenerative Diseases Market in recent years. Coverage includes Mergers and Acquisitions (M&As) as well as co-development and licensing agreements, which are segmented on the basis of geography and total value. A concomitant analysis of the licensing deal values for products by molecule types and is also provided.

Reasons to buy
The report will assist business development and marketing executives to strategize their product launches, by allowing them to - Understand the competitive environment for Neurodegenerative Diseases - Understand the clinical and commercial impact of major patent expiries in the neurodegenerative diseases markets - Assess the potential clinical and commercial impact of current latestage pipeline molecules on the neurodegenerative diseases market in the forecast period - Grasp the unmet need which exists in the neurodegenerative diseases Market - Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps

Table of Contents
1 Table of Contents 6 1.1 List of Tables 9 1.2 List of Figures 11 2 Neurodegenerative Diseases Market to 2018: Introduction 13 3 Neurodegenerative Diseases Market to 2018: Global Market Overview 14 3.1 Revenue 14 3.2 Treatment Usage Pattern 16 3.3 Distribution by Market 17 3.4 Drivers and Restraints of the Neurodegenerative Diseases Market 18 3.4.1 Drivers 18 3.4.2 Restraints 18 4 Therapeutic Landscape 19 4.1 Market for Alzheimer’s Disease 19 4.1.1 Introduction 19 4.1.2 Revenue and Forecasts 21

4.1.3 Treatment Usage Pattern 23 4.1.4 Geographical Landscape 24 4.1.5 Drivers and Restraints for the Alzheimer’s Disease Market 46 4.2 Market for Parkinson’s Disease 47 4.2.1 Introduction 47 4.2.2 Revenue and Forecasts 49 4.2.3 Treatment Usage Pattern 50 4.2.4 Geographical Landscape 51 4.2.5 Drivers and Restraints for the Parkinson’s Disease Market 73 4.3 Market for Amyotrophic Lateral Sclerosis 74 4.3.1 Introduction 74 4.3.2 Revenue and Forecasts 76 4.3.3 Treatment Usage Pattern 77 4.3.4 Geographical Landscape 78 4.3.5 Drivers and Restraints for the Amyotrophic Lateral Sclerosis Market 100

For More Information You Can Visit

Or visit us at:

Bharat Book Bureau
Phone : +91 22 27810772, 27810773 Toll Free No for USA/Canada : 1-866-279-8368 Fax : +91 22 27812290 E-mail : Website : Twitter: Blog: